[Pilot study evaluating the ratio of medication errors related to antimicrobials compared to their consumption].
BACKGROUND
As part of our antimicrobial stewardship program, we were interested in the use of anti-infectious drugs and the prevalence of medication errors associated with the use of these drugs.


METHODS
The retrospective and descriptive study was conducted over a 1-year-period between 1 April 2012 and 31 March 2013 in a teaching mother-child hospital. The aim of the study was to determine the number and the type of medication errors related to anti-infectious drugs. We evaluated the importance, the significance, and the severity of medication errors and at the same time we evaluated antimicrobial consumption. Therefore, we determined the ratio of medication errors per 10,000 defined daily doses (DDD) or 10,000 days of therapy (DOT). The secondary objective of the study was to compare the medication errors related to anti-infectious drugs with the data published in the Quebec Registry of Incidents and Accidents.


RESULTS
We found a total of 2164 medication errors including 301 (14%) medication errors related to anti-infectious drugs during the 2012-2013 fiscal year. The majority (95%) of the medication errors related to anti-infectious drugs was not harmful, with no consequences for the patient. Seventy-four percent of medication errors related to anti-infectious drugs were part of the C class on the severity scale. Omission (26%) and wrong dose administration were the two most frequently reported events. Eighty percent (n=242/301) of medication errors occurred during the administration step while only 8% (n=24/301) occurred during the prescribing step. Three anti-infectious drugs had the highest ratio of medication errors per 10,000 DDD or DOT: linezolid (376 medication errors per 10,000 DDD), doxycycline (357 medication errors per 10,000 DDD), and acyclovir (202 medication errors per 10,000 DDD). The nonparametric tests showed no significant differences between frequently used and infrequently used anti-infectious drugs for the ratio of medication errors per 10,000 DOT. This pilot study showed a ratio of 65.4 medication errors/10,000 DDD of anti-infectious drugs and a ratio of 41.9 medication errors/10,000 DOT of anti-infectious drugs.


CONCLUSIONS
The use of these ratios could contribute to focusing on monitoring anti-infectious drugs and improving the risk management system associated with this class of drugs. It also shows that less frequently used anti-infectious drugs should be managed with greater caution. Anti-infectious stewardship programs should also consider ratios of medication errors for anti-infectious drugs used in order to improve patient safety and optimize use of drugs.
Département de pharmacie, unité de recherche en pratique pharmaceutique, centre hospitalier Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, Montréal (QC), Canada, H3T 1C5.
C
C
Bérard
Département de pharmacie, unité de recherche en pratique pharmaceutique, centre hospitalier Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, Montréal (QC), Canada, H3T 1C5.
C
C
Cotteret
Département de pharmacie, unité de recherche en pratique pharmaceutique, centre hospitalier Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, Montréal (QC), Canada, H3T 1C5; Département de pharmacie, CHU Sainte-Justine, 3175 Côte-Sainte-Catherine, Montréal (QC), Canada, H3T 1C5.
D
D
Lebel
Département de pharmacie, unité de recherche en pratique pharmaceutique, centre hospitalier Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, Montréal (QC), Canada, H3T 1C5; Département de pharmacie, CHU Sainte-Justine, 3175 Côte-Sainte-Catherine, Montréal (QC), Canada, H3T 1C5; Faculté de pharmacie, université de Montréal, CP 6128, succursale Centre-ville, Montréal (QC), Canada, H3C 3J7. Electronic address: jf.bussieres@ssss.gouv.qc.ca.
J-F
JF
Bussières
D000890:Anti-Infective Agents / Q000008:administration & dosage*; D006784:Hospitals, Teaching; D006801:Humans; D008508:Medication Errors / Q000706:statistics & numerical data*; D061214:Patient Safety; D010865:Pilot Projects; D011792:Quebec; D012189:Retrospective Studies
D000890:Anti-Infective Agents